183 related articles for article (PubMed ID: 23982861)
1. Effective inhibition of nasopharyngeal carcinoma in vitro and in vivo by targeting glycolysis with oxamate.
Li X; Lu W; Hu Y; Wen S; Qian C; Wu W; Huang P
Int J Oncol; 2013 Nov; 43(5):1710-8. PubMed ID: 23982861
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of LDH-A by oxamate induces G2/M arrest, apoptosis and increases radiosensitivity in nasopharyngeal carcinoma cells.
Zhai X; Yang Y; Wan J; Zhu R; Wu Y
Oncol Rep; 2013 Dec; 30(6):2983-91. PubMed ID: 24064966
[TBL] [Abstract][Full Text] [Related]
3. Targeting aspartate aminotransferase in breast cancer.
Thornburg JM; Nelson KK; Clem BF; Lane AN; Arumugam S; Simmons A; Eaton JW; Telang S; Chesney J
Breast Cancer Res; 2008; 10(5):R84. PubMed ID: 18922152
[TBL] [Abstract][Full Text] [Related]
4. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression.
Su Y; Yu QH; Wang XY; Yu LP; Wang ZF; Cao YC; Li JD
BMC Cancer; 2017 Jul; 17(1):477. PubMed ID: 28693517
[TBL] [Abstract][Full Text] [Related]
5. Pectolinarigenin Suppresses the Tumor Growth in Nasopharyngeal Carcinoma.
Wang C; Cheng Y; Liu H; Xu Y; Peng H; Lang J; Liao J; Liu H; Liu H; Fan J
Cell Physiol Biochem; 2016; 39(5):1795-1803. PubMed ID: 27744436
[TBL] [Abstract][Full Text] [Related]
6. Synergistic anti-cancer effect of phenformin and oxamate.
Miskimins WK; Ahn HJ; Kim JY; Ryu S; Jung YS; Choi JY
PLoS One; 2014; 9(1):e85576. PubMed ID: 24465604
[TBL] [Abstract][Full Text] [Related]
7. Methylation-associated silencing of miR-9-1 promotes nasopharyngeal carcinoma progression and glycolysis via HK2.
Xu QL; Luo Z; Zhang B; Qin GJ; Zhang RY; Kong XY; Tang HY; Jiang W
Cancer Sci; 2021 Oct; 112(10):4127-4138. PubMed ID: 34382305
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of 3-bromopyruvate in human nasopharyngeal carcinoma cells.
Zou X; Zhang M; Sun Y; Zhao S; Wei Y; Zhang X; Jiang C; Liu H
Oncol Rep; 2015 Oct; 34(4):1895-904. PubMed ID: 26239511
[TBL] [Abstract][Full Text] [Related]
9. Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines.
Fiume L; Manerba M; Vettraino M; Di Stefano G
Pharmacology; 2010; 86(3):157-62. PubMed ID: 20699632
[TBL] [Abstract][Full Text] [Related]
10. Targeting nasopharyngeal carcinoma by artesunate through inhibiting Akt/mTOR and inducing oxidative stress.
Li Q; Ni W; Deng Z; Liu M; She L; Xie Q
Fundam Clin Pharmacol; 2017 Jun; 31(3):301-310. PubMed ID: 28078787
[TBL] [Abstract][Full Text] [Related]
11. Enhanced aerobic glycolysis of nasopharyngeal carcinoma cells by Epstein-Barr virus latent membrane protein 1.
Sung WW; Chen PR; Liao MH; Lee JW
Exp Cell Res; 2017 Oct; 359(1):94-100. PubMed ID: 28827059
[TBL] [Abstract][Full Text] [Related]
12. Targeting metabolic flexibility by simultaneously inhibiting respiratory complex I and lactate generation retards melanoma progression.
Chaube B; Malvi P; Singh SV; Mohammad N; Meena AS; Bhat MK
Oncotarget; 2015 Nov; 6(35):37281-99. PubMed ID: 26484566
[TBL] [Abstract][Full Text] [Related]
13. Effects of the suppression of lactate dehydrogenase A on the growth and invasion of human gastric cancer cells.
Liu X; Yang Z; Chen Z; Chen R; Zhao D; Zhou Y; Qiao L
Oncol Rep; 2015 Jan; 33(1):157-62. PubMed ID: 25394466
[TBL] [Abstract][Full Text] [Related]
14. Reactive oxygen species-mediated mitochondrial dysfunction is involved in apoptosis in human nasopharyngeal carcinoma CNE cells induced by Selaginella doederleinii extract.
Liu H; Peng H; Ji Z; Zhao S; Zhang Y; Wu J; Fan J; Liao J
J Ethnopharmacol; 2011 Oct; 138(1):184-91. PubMed ID: 21924341
[TBL] [Abstract][Full Text] [Related]
15. Isogarcinol inhibits nasopharyngeal carcinoma growth through mitochondria-mediated autophagic cell death.
Li J; Shen X; Sun C; Hou Y; Hu Y; Ma S; Huang L; Ma L; Zhang Y; Dai X
Phytomedicine; 2024 Jul; 130():155745. PubMed ID: 38833788
[TBL] [Abstract][Full Text] [Related]
16. Modification of tumour glucose metabolism for therapeutic benefit.
Hamilton E; Fennell M; Stafford DM
Acta Oncol; 1995; 34(3):429-33. PubMed ID: 7779436
[TBL] [Abstract][Full Text] [Related]
17. ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma.
Wang Y; Wang Y; Fan X; Song J; Wu H; Han J; Lu L; Weng X; Nie G
Biochem Biophys Res Commun; 2018 Sep; 503(3):1214-1220. PubMed ID: 30017199
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effect of TMZ-POH on human nasopharyngeal carcinoma depends on reactive oxygen species accumulation.
Xie L; Song X; Guo W; Wang X; Wei L; Li Y; Lv L; Wang W; Chen TC; Song X
Oncotarget; 2016 Jan; 7(2):1651-62. PubMed ID: 26625208
[TBL] [Abstract][Full Text] [Related]
19. Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.
Hui KF; Ho DN; Tsang CM; Middeldorp JM; Tsao GS; Chiang AK
Int J Cancer; 2012 Oct; 131(8):1930-40. PubMed ID: 22261816
[TBL] [Abstract][Full Text] [Related]
20. Different effects of LDH-A inhibition by oxamate in non-small cell lung cancer cells.
Yang Y; Su D; Zhao L; Zhang D; Xu J; Wan J; Fan S; Chen M
Oncotarget; 2014 Dec; 5(23):11886-96. PubMed ID: 25361010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
